GlassScriptPhysician profile
Yara Matta
NPI 1073932133
$4,138.40
in general payments reported to CMS, 2019-2025
33 companies · $960 in 2025
The $960 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $210 · 2021: $433 · 2022: $645 · 2023: $729 · 2024: $778 · 2025: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,435 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,434.95 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $830.82 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $650.97 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $561.49 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Abbvie INC. | $236.73 | 2019-2025 | |
| Glaxosmithkline, LLC. | $231.06 | 2023-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $189.78 | 2020-2025 | |
| Abbott Laboratories | $184.75 | 2022-2025 | Freestyle Libre 3 |
| Cranial Technologies, INC | $161.48 | 2020-2025 | Doc Band |
| Amgen INC. | $116.84 | 2020-2025 | Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.63 | 2022-2025 | Jardiance, Tradjenta |
| Merck Sharp & Dohme LLC | $99.07 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $82.88 | 2021 | |
| Inspire Medical Systems, INC. | $74.92 | 2025 | Inspire |
| Exact Sciences Corporation | $69.54 | 2023-2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $51.89 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $48.93 | 2022 | |
| Therapeuticsmd, INC. | $47.39 | 2019 | |
| Organon LLC | $40.18 | 2022-2023 | Nexplanon |
| Edwards Lifesciences Corporation | $39.98 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Astellas Pharma US INC | $33.45 | 2025 | Veozah |
| Harmony Biosciences LLC | $31.38 | 2022 | |
| Hologic Sales and Service, LLC | $31.14 | 2024 | Aptima |
| Idorsia Pharmaceuticals US INC | $27.80 | 2023 | Quviviq |
| Irhythm Technologies, INC. | $25.05 | 2024 | Zio Xt Patch, Zio Monitor |
| Si-Bone, INC. | $24.69 | 2019 | |
| Genentech USA, INC. | $24.59 | 2021 | |
| Tactile Systems Technology INC | $18.03 | 2022 | |
| Phadia US INC. | $17.76 | 2024 | Immunocap |
| Horizon Therapeutics Plc | $17.23 | 2021 | |
| Amarin Pharma, INC. | $16.66 | 2020 | |
| Janssen Pharmaceuticals, INC | $15.18 | 2020 | |
| Daiichi Sankyo INC. | $14.97 | 2024 | Injectafer |
| Abiomed | $13.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yara Matta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.